A Case of Pla2r and Exostosin 1 Positive Membranous Nephropathy - The Diagnostic and Therapeutic Dilemma. [PDF]
Sivagnanam H +4 more
europepmc +1 more source
An interstitial deletion at 8q23.1-q24.12 associated with Langer-Giedion syndrome/ Trichorhinophalangeal syndrome (TRPS) type II and Cornelia de Lange syndrome 4 [PDF]
core +1 more source
Multi-Omics and Single-Cell Dissection of Exostosin Glycosyltransferases (EXT1/EXT2) Reveals Divergent Oncogenic Roles and Therapeutic Vulnerabilities in Gliomas. [PDF]
Chiang YC +24 more
europepmc +1 more source
Membranous nephropathy - an antigen-specific disease: a paradigm shift in the understanding of this disease. [PDF]
Rajagopal MD, Stephen N, Manoharan K.
europepmc +1 more source
Exostosin 1 (EXT1) and exostosin 2 (EXT2)-associated membranous nephropathy (MN) may be associated with active autoimmune disease. We encountered an elderly man who presented with EXT1/EXT2-associated lupus-like MN with full house immune deposits, monoclonal gammopathy of uncertain significance and Sjögren’s syndrome.
openaire
Distinction Between Proliferative Lupus Nephritis and Membranous Lupus Nephritis Based on Inflammation, NETosis, and Glomerular Exostosin. [PDF]
Wada Y +8 more
europepmc +1 more source
Clinical profile and outcome of primary membranous nephropathy: A tertiary care center experience from North India. [PDF]
Wani MA +7 more
europepmc +1 more source
Long-term outcomes in primary membranous nephropathy: a Chinese cohort study with novel target antigen. [PDF]
Guo P +7 more
europepmc +1 more source
EXT1/EXT2-Associated Membranous Nephropathy Secondary to TAFRO Syndrome: A Case Report. [PDF]
Kamido H +10 more
europepmc +1 more source
Palovarotene for patients with multiple hereditary exostosis: results of MO-Ped, a terminated, randomized, placebo-controlled, double-blind phase 2 trial. [PDF]
Sangiorgi L +4 more
europepmc +1 more source

